Related Articles
Association of KRAS, NRAS, BRAF and PIK3CA gene mutations with clinicopathological features, prognosis and ring finger protein 215 expression in patients with colorectal cancer
Prevalence of KRAS, BRAF, PI3K and EGFR mutations among Asian patients with metastatic colorectal cancer
Prognostic value of KRAS/TP53/PIK3CA in non‑small cell lung cancer
Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome
Impact of genetic profiles on the efficacy of anti-EGFR antibodies in metastatic colorectal cancer with KRAS mutation